<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-05T18:25:53Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/68951" metadataPrefix="didl">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/68951</identifier><datestamp>2025-09-11T06:51:03Z</datestamp><setSpec>com_10324_1138</setSpec><setSpec>com_10324_931</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_1226</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
<d:DIDLInfo>
<dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2024-07-22T10:03:20Z</dcterms:created>
</d:DIDLInfo>
<d:Item id="hdl_10324_68951">
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10324/68951</dii:Identifier>
</d:Statement>
</d:Descriptor>
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Silicone microbubbles after anti‐vascular endothelial growth factor injections in patients with wet age‐related macular degeneration: incidence, quantification and secondary optical coherence tomography artfacts</dc:title>
<dc:creator>Sanabria Ruiz Colmenares, María Rosa</dc:creator>
<dc:creator>Alonso Tarancón, Ana María</dc:creator>
<dc:creator>Calles Monar, Paola Stefanía</dc:creator>
<dc:creator>Ibañez, Patricia</dc:creator>
<dc:creator>García de Arriba, Santiago</dc:creator>
<dc:creator>Alvarez, Nuria</dc:creator>
<dc:creator>Piñuel, Jesús A.</dc:creator>
<dc:creator>Coco Martín, Rosa María</dc:creator>
<dc:creator>Fernández Martínez, Itziar</dc:creator>
<dc:description>Producción Científica</dc:description>
<dc:description>ABSTRACT. PURPOSE: To report the incidence and quantity of silicone oil microbubbles and the relationship with the number of intravitreal anti-vascular endothelial growth factor (VEGF) injections and evaluate if microbubbles induce artefacts on optical coherence tomography (OCT) images. METHODS: Observational, descriptive, cross-sectional study. Patients with wet age-related macular degeneration were included who had been treated for 1 year minimally with anti-VEGF injections repackaged in the hospital pharmacy. Detection and quantification of silicone microbubbles by mydriatic biomicroscopic examination were conducted 1 month after the last injection. The numbers of microbubbles were quantified on a scale of 0–3: 0, none; 1 scarce (1–10 microbubbles); 2 moderate (10–30); or 3 numerous (>30). Shadowing on OCT images was classified as 0–3: 0, none; 1 obscuring some retinal layers; 2 obscuring all retinal layers; or 3 obscuring the retinal thickness. RESULTS: The study included 142 eyes of 98 patients (mean age, 82.4 years + 7.3; range, 65–97) treated with 2377 injections. Microbubbles were detected in 127 (89.4%) eyes, 62 (43.6%) with numerous microbubbles and 36 (25.4%) and 29 (20.4%), respectively, with scarce and moderate numbers. A positive correlation was found between the numbers of injections and intravitreal silicone (rho, 0.7). Optical coherence tomography (OCT) artefacts were detected in 11 eyes; the artefacts obscured all retinal layers in three eyes. No significant relationship could be established between the appearance of floaters and the microbubbles. CONCLUSION: The presence and number of silicone microbubbles were correlated with the number of intravitreal injections. Microbubbles can produce OCT artefacts, which can hinder the treatment decision.</dc:description>
<dc:date>2024-07-22T10:03:20Z</dc:date>
<dc:date>2024-07-22T10:03:20Z</dc:date>
<dc:date>2021</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>Acta Ophthalmol, Nov, 2021, vol. 99, n. 7, p. e1051-e1055.</dc:identifier>
<dc:identifier>1755-375X</dc:identifier>
<dc:identifier>https://uvadoc.uva.es/handle/10324/68951</dc:identifier>
<dc:identifier>10.1111/aos.14743</dc:identifier>
<dc:identifier>e1051</dc:identifier>
<dc:identifier>7</dc:identifier>
<dc:identifier>e1055</dc:identifier>
<dc:identifier>Acta Ophthalmologica</dc:identifier>
<dc:identifier>99</dc:identifier>
<dc:identifier>1755-3768</dc:identifier>
<dc:language>spa</dc:language>
<dc:relation>https://pubmed.ncbi.nlm.nih.gov/33421336/</dc:relation>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
<dc:rights>Wiley</dc:rights>
<dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
<dc:publisher>Wiley Online Library</dc:publisher>
</oai_dc:dc>
</d:Statement>
</d:Descriptor>
<d:Component id="10324_68951_1">
<d:Resource ref="https://uvadoc.uva.es/bitstream/10324/68951/1/12.-microbubbles%20AA7AS.docx" mimeType="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</d:Component>
</d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>